Sivits, Glenn
Amgen (United States)
4 papers on CoChatORCID 0000-0002-9621-5449
Most cited papers
- Verified
Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice
Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes
Fibroblast Growth Factor ResearchLiver Disease Diagnosis and Treatment
Cited by 1,151
- Verified
Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models
Killion, E. A., Wang, J., Yie, J., Shi, S. D.-H., Bates, D., Min, X., Komorowski, R., Hager, T., Deng, L., Atangan, L., et al. (2018) · Science Translational Medicine
Regulation of Appetite and ObesityPharmacology and Obesity Treatment
Cited by 237
- Verified
Pharmacologic Effects of FGF21 Are Independent of the “Browning” of White Adipose Tissue
Véniant, M. M., Sivits, G., Helmering, J., Komorowski, R., Lee, J., Fan, W., Moyer, C., & Lloyd, D. J. (2015) · Cell Metabolism
Fibroblast Growth Factor ResearchAdipose Tissue and Metabolism
Cited by 204
- Verified
Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism
Killion, E. A., Chen, M., Falsey, J. R., Sivits, G., Hager, T., Atangan, L., Helmering, J., Lee, J., Li, H., Wu, B., et al. (2020) · Nature Communications
Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases
Cited by 151
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free